Study Stopped
No funding for the project
Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients
The Effect of Inhaled Mannitol on Ciliary Beat Frequency in COPD Patients
No funding for the project
The Effect of Inhaled Mannitol on Ciliary Beat Frequency in COPD Patients
Sponsor study identifier
observational
0
1 country
1
Study Start
January 2010
Actual (reported)Primary Completion
January 2012
Actual (reported)Study Completion
January 2012
Actual (reported)The main purpose of the study is to evaluate the effect of mannitol on the cilia's beat frequency (ciliary beat frequency) in COPD patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2012
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 9, 2007
Actual (reported)March 12, 2007
Actual (reported)January 2010
Actual (reported)January 2012
Actual (reported)January 2012
Actual (reported)patients with COPD
Contact the study team to confirm eligibility.
Airway Disease Section, Asthma Lab, Imperial College London, Royal Brompton Hospital
London, SW3 6LY, United Kingdom
Sergei Kharitonov, MD PhD
Imperial College London
0 participants (actual enrollment reported by the registry).
First Submitted
March 9, 2007
First Posted
March 12, 2007
Study Start
January 2010
Actual (reported)Osteoprotegerin (OPG) in Induced Chronic Obstructive Pulmonary Disease (COPD) Sputum
Primary Completion
January 2012
Actual (reported)Study Completion
January 2012
Actual (reported)Last Updated
April 4, 2024
Record last verified: 2024-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: